Evidence map›Paper›PMID 32028132›Full record

ArticleColloids and surfaces. B, Biointerfaces2020

Direct incorporation of nano graphene oxide (nGO) into hydrophobic drug crystals for enhanced aqueous dissolution.

Mohammad Saiful Islam, Faradae Renner, Samar Azizighannad, Somenath Mitra

Open access · greenAbstract read
In one paragraph

Article in Colloids and surfaces. B, Biointerfaces, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohammad Saiful IslamDepartment of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA.
Faradae RennerDepartment of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA.
Samar AzizighannadDepartment of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA.
Somenath MitraDepartment of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA. Electronic address: somenath.mitra@njit.edu.
New Jersey Institute of Technology · US

Funding

Dietary DHA attenuation of nanoparticle inflammationR01ES023209 · NIEHS · UNIVERSITY OF MONTANA · PI HOLIAN, ANDRIJ · 2014 to 2018
$2.8M
NIEHS NIH HHS R01 ES023209
6 · The paper itself

Abstract

This paper reports the development of a successful anti-solvent method that incorporates colloidal nano scale graphene oxide (nGO) directly into hydrophobic drug crystals. The nGO dispersed in solution acted as nucleating sites for crystallization and were embedded into the drug crystals without altering its structure or physical properties such as melting point. Several composites of drugs Sulfamethoxazole and Griseofulvin were synthesized with nGO concentration ranging between 0.2 and 1.0 %. The presence of nGO dramatically enhanced the dissolution rate. The time needed to reach a 50 % release (T

Indexed as

CrystallizationGraphiteGriseofulvinHydrophobic and Hydrophilic InteractionsNanoparticlesParticle SizeSolubilitySulfamethoxazoleSurface PropertiesWatergraphene oxideGraphiteGriseofulvinSulfamethoxazoleWaterAntisolvent precipitationBioavailabilityDissolution rateDrug deliveryGraphene oxideHydrophobic drugsNanoparticle

Identifiers

PMID32028132
PMCPMC7160045
OpenAlexW3004239554

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.